CARMELA: Assessment of Cardiovascular Risk in Seven Latin American Cities

American Journal of Medicine

Volumn 121, Issue 1, 2008, Pages 58-65

  Schargrodsky, Herman ^a   Hernández Hernández, Rafael ^b   Champagne, Beatriz Marcet ^c   Silva, Honorio ^d   Vinueza, Raúl ^d   Silva Ayçaguer, Luis Carlos ^e   Touboul, Pierre Jean ^f   Boissonnet, Carlos Pablo ^g   Escobedo, Jorge ^h   Pellegrini, Fabio ⁱ   Macchia, Alejandro ⁱ   Wilson, Elinor ^j  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^b UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^c InterAmerican Heart Foundation   (United States)

^d PFIZER INC   (United States)

^e CENTRO NACIONAL DE INFORMACIÓN DE CIENCIAS MÉDICAS   (Cuba)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g CEMIC   (Argentina)

^h INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

ⁱ Consorzio Mario Negri Sud ^*  (Italy)

^j HEALTH CANADA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTERIAL WALL THICKNESS; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERVIEW; LIPID BLOOD LEVEL; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LATIN AMERICA; LIPIDS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TUNICA INTIMA; URBAN POPULATION;

EID: 37749052737     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2007.08.038     Document Type: Article

References (30)

1. Omran A. The epidemiologic transition: a theory of the epidemiology of population change. Millbank Memorial Fund Q 49 (1971) 509-538
2. Yusuf S., Reddy S., Ounpuu S., and Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104 (2001) 2746-2753
3. World Health Organization. The World Health Report: Reducing Risks, Promoting Healthy Life (2002), World Health Organization, Geneva
4. Ordunez P., Silva L.C., Rodriguez M.P., and Robles S. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance?. Rev Panam Salud Publica 10 (2001) 226-231
5. World Health Organization. Preventing Chronic Diseases: A Vital Investment (2005), World Health Organization, Geneva
6. Torres M.I., Quiroga S.E., and Farinati Z.J. Pilot external quality assessment scheme for serology determinations in Latin America. Clin Chem Lab Med 37 (1999) S299 Special Supplement
7. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
8. National Cholesterol Education Program Adult Treatment Panel III. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
9. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1 (2003) S5-S20
10. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim intima-media thickness consensus. Cerebrovasc Dis 18 (2004) 346-349
11. Kearney P.M., Whelton M., Reynolds K., et al. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
12. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
13. Ford E.S., Mokdad A.H., Giles W.H., and Mensah G.A. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 107 (2003) 2185-2189
14. World Health Organization. Obesity: Preventing and Managing the Global Epidemic (2000), World Health Organization, Geneva
15. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
16. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
17. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
18. Must A., Spadano J., Coakley E.H., et al. The disease burden associated with overweight and obesity. JAMA 282 (1999) 1523-1529
19. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28 (2005) 1769-1778
20. Reddy K.S., and Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97 (1998) 596-601
21. Ezzati M., Vander Hoorn S., Lawes C.M., et al. Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med 2 (2005) e133
22. United Nations Development Programme. Human Development Report 2005 International Cooperation at a Crossroads: Aid, Trade and Security in an Unequal World (2005), United Nations, New York
23. Lopez A.D., Collishaw N.E., and Piha T. A descriptive model of the cigarette epidemic in developed countries. Tob Control 3 (1994) 242-247
24. World Conference on Tobacco or Health. Tobacco Control Country Profiles (2003), American Cancer Society, World Health Organization, and International Union Against Cancer
25. Bots M.L. Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 22 (2006) 2181-2190
26. Touboul P.J., Vicaut E., Labreuche J., et al. Design, baseline characteristics and carotid intima-media thickness reproducibility in the PARC study. Cerebrovasc Dis 19 (2005) 57-63
27. Castelli W.P. Epidemiology of coronary heart disease: the Framingham study. Am J Med 76 (1984) 4-12
28. Stamler J. Established major coronary risk factors. In: Marmot M., and Elliott P. (Eds). Coronary Heart Disease: From Aetiology to Public Health (1992), Oxford University Press
29. Brindle P., Emberson J., Lampe F., et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 327 (2003) 1267
30. Lanas F., Avezum A., Bautista L.E., et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 115 (2007) 1067-1074